Geneos Wealth Management’s Equifax EFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$13K Buy
95
+15
+19% +$2.61K ﹤0.01% 2291
2026
Q2
$12.7K Hold
80
– – ﹤0.01% 1939
2026
Q1
$14.4K Hold
80
– – ﹤0.01% 1887
2025
Q4
$17.4K Hold
80
– – ﹤0.01% 1779
2025
Q3
$20.5K Sell
80
-321
-80% -$80.7K ﹤0.01% 1716
2025
Q2
$104K Buy
401
+58
+17% +$14.8K ﹤0.01% 1232
2025
Q1
$83.5K Buy
343
+102
+42% +$25.6K ﹤0.01% 1236
2024
Q4
$61.4K Buy
241
+3
+1% +$804 ﹤0.01% 1242
2024
Q3
$69.9K Buy
238
+44
+23% +$12.4K ﹤0.01% 1076
2024
Q2
$47K Buy
194
+114
+143% +$27.2K ﹤0.01% 1092
2024
Q1
$21.4K Sell
80
-113
-59% -$28.8K ﹤0.01% 1340
2023
Q4
$47.8K Hold
193
– – ﹤0.01% 1077
2023
Q3
$35.4K Buy
193
+80
+71% +$16.3K ﹤0.01% 1181
2023
Q2
$26.6K Hold
113
– – ﹤0.01% 1277
2023
Q1
$22.9K Buy
+113
New +$23.5K ﹤0.01% 1302
2021
Q2
– Sell
-621
Closed -$142K – 2920
2021
Q1
$142K Buy
+621
New +$110K ﹤0.01% 1137
2020
Q4
– Sell
-1,101
Closed -$172K – 2919
2020
Q3
$172K Hold
1,101
– – 0.01% 733
2020
Q2
$184K Hold
1,101
– – 0.01% 693
2020
Q1
$131K Hold
1,101
– – 0.01% 751
2019
Q4
$154K Sell
1,101
-245
-18% -$33.9K 0.01% 796
2019
Q3
$190K Hold
1,346
– – 0.01% 675
2019
Q2
$182K Sell
1,346
-200
-13% -$25.1K 0.01% 702
2019
Q1
$183K Hold
1,546
– – 0.01% 669
2018
Q4
$143K Sell
1,546
-100
-6% -$10.6K 0.01% 715
2018
Q3
$214K Hold
1,646
– – 0.01% 616
2018
Q2
$205K Sell
1,646
-81
-5% -$9.6K 0.02% 563
2018
Q1
$203K Hold
1,727
– – 0.02% 539
2017
Q4
$203K Buy
1,727
+200
+13% +$22.5K 0.02% 533
2017
Q3
$161K Buy
1,527
+81
+6% +$10.7K 0.02% 571
2017
Q2
$198K Hold
1,446
– – 0.02% 500
2017
Q1
$197K Hold
1,446
– – 0.02% 485
2016
Q4
$170K Hold
1,446
– – 0.02% 491
2016
Q3
$194K Hold
1,446
– – 0.03% 452
2016
Q2
$185K Hold
1,446
– – 0.03% 460
2016
Q1
$168K Hold
1,446
– – 0.03% 468

Other funds holding EFX

Geneos Wealth Management's EFX Position: Q3 2026 in Review

Geneos Wealth Management increased its Equifax (EFX) stake by 19% in Q3 2026, buying an estimated $2.61K and bringing the position to 95 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #2291.

Geneos Wealth Management first reported a position in EFX in Q1 2016 and has held it in 35 quarters since. The position peaked at $214K in Q3 2018. 793 funds tracked by Wall St. Rank hold EFX as of Q3 2026.

  • Geneos Wealth Management held 95 shares of Equifax worth $13K as of Q3 2026.
  • Geneos Wealth Management bought 15 Equifax shares in Q3 2026, an estimated $2.61K.
  • Equifax made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #2291 holding.
  • Geneos Wealth Management first reported a position in Equifax in Q1 2016 and has held it in 35 quarters since.
  • Geneos Wealth Management's Equifax position peaked at $214K in Q3 2018.
  • 793 funds tracked by Wall St. Rank held Equifax as of Q3 2026.

Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.